Transforming Growth Factor-β1 is Constitutively Secreted by Chinese Hamster Ovary Cells and is Functional in Human Cells

被引:31
作者
Beatson, Richard [1 ]
Sproviero, Daisy [1 ]
Maher, John [1 ]
Wilkie, Scott [1 ]
Taylor-Papadimitriou, Joyce [1 ]
Burchell, Joy M. [1 ]
机构
[1] Kings Coll London, Guys Hosp, London SE1 9RT, England
关键词
Chinese hamster ovary cells; CHO; TGF beta; recombinant proteins; TGFbeta; TGF-BETA; GROWTH; CHO;
D O I
10.1002/bit.23217
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Chinese hamster ovary (CHO) cells are widely used for the production of recombinant proteins for clinical use as well as academic research. They are particularly important for the production of glycoproteins where bacteria cannot be used. TGF beta 1 is a potent cytokine highly conserved across species with multiple immunological and non-immunological effects. We have discovered that CHOK1, the CHO clone most commonly used by the pharmaceutical industry, constitutively secretes latent TGF beta 1 and that this hamster TGF beta 1 is active on human cells inducing profound immunological effects. As far as we are aware, the production of TGF beta 1 by CHOK1 cells has not been reported before in the literature. As TGF beta 1 exerts powerful and pleiotropic effects on diverse cell types, and as CHO cells are used to produce a large number of clinical and non-clinical products, our findings are highly relevant to studies that rely on recombinant proteins. Biotechnol. Bioeng. 2011; 108: 2759-2764. (C) 2011 Wiley Periodicals, Inc.
引用
收藏
页码:2759 / 2764
页数:6
相关论文
共 18 条
[1]   AN ASSAY FOR TRANSFORMING GROWTH-FACTOR-BETA USING CELLS TRANSFECTED WITH A PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROMOTER LUCIFERASE CONSTRUCT [J].
ABE, M ;
HARPEL, JG ;
METZ, CN ;
NUNES, I ;
LOSKUTOFF, DJ ;
RIFKIN, DB .
ANALYTICAL BIOCHEMISTRY, 1994, 216 (02) :276-284
[2]   Making sense of latent TGFβ activation [J].
Annes, JP ;
Munger, JS ;
Rifkin, DB .
JOURNAL OF CELL SCIENCE, 2003, 116 (02) :217-224
[3]   Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells [J].
Bäckström, M ;
Link, T ;
Olson, FJ ;
Karlsson, H ;
Graham, R ;
Picco, G ;
Burchell, J ;
Taylor-Papadimitriou, J ;
Noll, T ;
Hansson, GC .
BIOCHEMICAL JOURNAL, 2003, 376 :677-686
[4]   An α2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas [J].
Burchell, J ;
Poulsom, R ;
Hanby, A ;
Whitehouse, C ;
Cooper, L ;
Clausen, H ;
Miles, D ;
Taylor-Papadimitriou, J .
GLYCOBIOLOGY, 1999, 9 (12) :1307-1311
[5]   Adaptive human regulatory T cells: myth or reality? [J].
Chatenoud, Lucienne ;
Bach, Jean-Francois .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (09) :2325-2327
[6]  
Derynck R., 2008, TGF-beta and the TGF-beta family, P29
[7]   Transforming Growth Factor-Beta 1 (TGF-β1) Induces Angiogenesis Through Vascular Endothelial Growth Factor (VEGF)-Mediated Apoptosis [J].
Ferrari, Giovanni ;
Cook, Brandoch D. ;
Terushkin, Vitaly ;
Pintucci, Giuseppe ;
Mignatti, Paolo .
JOURNAL OF CELLULAR PHYSIOLOGY, 2009, 219 (02) :449-458
[8]   P15(INK4B) IS A POTENTIAL EFFECTOR OF TGF-BETA-INDUCED CELL-CYCLE ARREST [J].
HANNON, GJ ;
BEACH, D .
NATURE, 1994, 371 (6494) :257-261
[9]   Intravenous immunoglobulins and transforming growth factor β [J].
Kekow, J ;
Reinhold, D ;
Pap, T ;
Ansorge, S .
LANCET, 1998, 351 (9097) :184-185
[10]   POTENTIAL ROLE OF WAF1/CIP1/P21 AS A MEDIATOR OF TGF-BETA CYTOINHIBITORY EFFECT [J].
LI, CY ;
SUARDET, L ;
LITTLE, JB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (10) :4971-4974